A secondary analysis of a clinical trial has shown that when all patients with type 2 diabetes received comparable diabetes-related care, black race was not associated with accelerated kidney function decline, and fewer black participants developed chronic kidney disease.

In the general population, blacks have a disproportionate burden of diabetes-related complications.